MICHELLE ROBINSON: Open Payments
NPI 1558547919 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 72 payments from 10 companies in 2025. Trend: 2023 $903 · 2024 $1,242 · 2025 $1,229
Food & beverage: $1,229
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $264 |
| PFIZER INC. | 15 | $234 |
| Lilly USA, LLC | 16 | $214 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $176 |
| ABBVIE INC. | 12 | $159 |
| GlaxoSmithKline, LLC. | 4 | $63 |
| Novo Nordisk Inc | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: MOUNJARO, Kerendia, NURTEC ODT, BREZTRI, QULIPTA, AIRSUPRA, ELIQUIS, TRELEGY ELLIPTA.
Industry payments across AR — which companies pay providers there.
